Term
Pronouned hypotension during anesthesia is often associated with what two things |
|
Definition
Volume Depletion and Cardiac insufficiency |
|
|
Term
With autonomic pharmacological interventions, what can be used to increase heart rate? |
|
Definition
|
|
Term
With autonomic pharmacological interventions, what effects does a sympathomimetic cause? |
|
Definition
Increase heart rate, cardiac contractility, and vasoconstriction |
|
|
Term
What signs of adequate anesthesia are lost during NMJ blockade? |
|
Definition
Reflexes, muscle tone, respiratory rate, and depth of anesthesia |
|
|
Term
With NMJ blocks, what parameters can be looked at to asses adequate anesthesia? |
|
Definition
Blood Pressure, Heart rate, and temperature (Influenced by autonomic drugs) |
|
|
Term
Describe the critical condition of shock. |
|
Definition
Poor delivery of oxygen and nutrients to vital organs resulting in a hypotensive state |
|
|
Term
What are the three types of shock? |
|
Definition
Hypovolemic, Distributive, Cardiogenic |
|
|
Term
Describe Hypovolemic Shock |
|
Definition
Intravascular volume deficit |
|
|
Term
Describe Distributive Shock |
|
Definition
Peripheral vasodilation (Examples: Septic, anaphylactic, and neurogenic)
You make the swimming pool bigger without adding any more water! |
|
|
Term
Describe Cardiogenic Shock |
|
Definition
|
|
Term
What are three key responses to a hypotensive system? |
|
Definition
Reflex resonse to restore BP and preserve organ perfusion, activation of renin-angiotensin system, and increase in sympathetic flow |
|
|
Term
An increase in sympathetic outflow causes what? |
|
Definition
Increase in heart rate,contractility, CO, TPR, and BP and vasoconstriction |
|
|
Term
|
Definition
|
|
Term
T or F: If you have increased Sympathetic Outflow, you need to address the underlying cause regardless of compensation |
|
Definition
|
|
Term
Inadequate sympathetic compensation is achieved through what? |
|
Definition
Autonomic drugs (sympathetics), Increased cardiac output (B1 stim), and increased peripheral resistance (alpha1) |
|
|
Term
What Is an inadequate, short-term solution to sympathetic compensation? |
|
Definition
|
|
Term
Shock associated vasoconstriction causes what? |
|
Definition
Increased TPR, maldistribution of blood flow, tissue ischemia/infarction, aliguria/anuria |
|
|
Term
What is enhanced by sympathomimetics? |
|
Definition
Beta 1 or alpha 1 stimulation |
|
|
Term
What do sympathomimetics cause? |
|
Definition
Increased BP, CO, and TPR |
|
|
Term
What are two autonomic innervations? |
|
Definition
Maintain BP and Perfuse vital organs |
|
|
Term
List the sympathetic agonists that are given IV |
|
Definition
Dopamine, Norepinephrine, epinephrine, and phenylephrine |
|
|
Term
Describe the low dose (1-10μg/kg) effects of Dopamine |
|
Definition
1- stimulates vascular D1 dopamine receptors, 2-increased renal blood flow and sodium excretion, 3-stimulates cardiac Beta 1 receptors, 4-positive inotropic effect |
|
|
Term
Describe the high dose (>10μg/kg) effects of Dopamine |
|
Definition
1-Stimulate vascular Alpha1 receptors, 2-Vasoconstriction |
|
|
Term
Norepinephrine (NE) and Epinephrine (EPI) potency on Beta1 |
|
Definition
|
|
Term
Norepinephrine (NE) and Epinephrine (EPI) potency on Beta2 |
|
Definition
|
|
Term
Norepinephrine (NE) and Epinephrine (EPI) potency on apha |
|
Definition
|
|
Term
EPI excessively stimulates what receptor? |
|
Definition
|
|
Term
NE vs EPI: what is prefered for maintaining blood pressure during shock associated with vasodilation |
|
Definition
|
|
Term
What is the primary therapy for Anaplylactic Shock? |
|
Definition
|
|
Term
What key effects are caused by epinephrine? |
|
Definition
Cardiovascular support, bronchodilation, inhibits mast cell degranulation |
|
|
Term
What drug is a prototypical selective alpha1 adrenergic agonist? |
|
Definition
|
|
Term
Dobutamine had complex agonist activity on what receptors? |
|
Definition
|
|
Term
What are the cardiovascular effects of Dobutamine? |
|
Definition
1-Increased cardiac contractility, 2-minimal vascular-dependent changes in BP, 3 - Increased CO and BP |
|
|
Term
What treatment is appropriate when you have a mix of mypcardial insufficiency and vasodilation |
|
Definition
Moderate infusion of dopamine |
|
|
Term
What influences your choice/dose of drug? |
|
Definition
1-rational decision based on pharmacology, 2-what worked in the past, 3-what is working now |
|
|
Term
What is the goal in treating shock? |
|
Definition
To establish and maintain perfusion |
|
|
Term
What is an autonomic agent you could use during shock that causes minimal vasoconstriction? |
|
Definition
Dobutamine or low dose dopamine |
|
|
Term
What is an autonomic agent you could use during shock that causes maximal vasoconstriction? |
|
Definition
|
|
Term
What is the definition of Glaucoma? |
|
Definition
Disease in which the pressure in the eye is too high (leads to increased intraocular pressure and vision loss) |
|
|
Term
What is the difference between primary and secondary glaucoma? |
|
Definition
Primary shows increased intraocular pressure in the absence of signs of concurrent ocular disease while secondary is associated with concurrent ocular disease. |
|
|
Term
What is a key concurrent ocular disease in secondary glaucoma? |
|
Definition
|
|
Term
What kind of angle is present in Primary glaucoma? |
|
Definition
Narrow angle (EXCEPTION - Beagles have an open angle) |
|
|
Term
What are the goals of autonomic drugs given topically for Glaucoma? |
|
Definition
1-manage primary glaucoma, 2-adjunct to surgical treatment, 3-lower intraocular pressure |
|
|
Term
What is a beta agonist used for Glaucoma treatment and what are its effects? |
|
Definition
Timolol = 1-decrease aqueaous humor production, 2-systemic effects |
|
|
Term
What are the effects of alpha 2 agaonists when used for glaucoma? |
|
Definition
1-decrease aqueous humor production, 2-limits CNS effects, 3-ionized a physiological pH |
|
|
Term
What is a cholinergic agonist used for Glaucoma treatment and what are its effects? |
|
Definition
Pilocarpine = 1-miotic agents that increase aqueous outflow, 2-open the closed angle, 3-used with timolol |
|
|
Term
The heart contracts in which two manners? |
|
Definition
sequentially and synchronized |
|
|
Term
|
Definition
The flow of electric charge |
|
|
Term
Cardiac electrical activity originates where? |
|
Definition
|
|
Term
Cardiac electrical activity spreads rapidly throughout the ventricles via what? |
|
Definition
|
|
Term
Electrical current spreads from one cell to another via what? |
|
Definition
|
|
Term
Where does cardiac electrical activty come from? |
|
Definition
It arises from diverse populations of ion channels throughout the heart |
|
|
Term
At rest, what is the charge of the interior of the cell in respect to the exterior? |
|
Definition
The interior of the cell is negative (-90mV) with respect to the exterior |
|
|
Term
What are three major ions for membrane potential? |
|
Definition
sodium, calcium, potassium |
|
|
Term
Each ion will naturally drive the cell membrane potential towards what if it is allowed to move freely in or out of the cell? |
|
Definition
Its own reversal potential |
|
|
Term
At rest the cell is permeable to which ion? |
|
Definition
|
|
Term
What happens when sodium channels open? |
|
Definition
|
|
Term
What is activated by depolarization? |
|
Definition
voltage-gated sodium channels |
|
|
Term
Ion channels generally have what 3 basic functional states? |
|
Definition
1-Closed (pore is shut/no current), 2-open (pore is open/current), 3-inactivated (pore is open but blocked/no current) |
|
|
Term
What is the threshold for activation of voltage-gated sodium channels? |
|
Definition
|
|
Term
Describe calcium channels |
|
Definition
1-selectively permeable to Calcium, 2-open slowly, 3-inactivate slowly, 4-recover from inactivation only by repolarizing |
|
|
Term
What is the threshold for activation of voltage-dependent calcium channels? |
|
Definition
|
|
Term
What is a key result of calcium channels inactivating slowly? |
|
Definition
It allows for substantial calcium influx to trigger contraction |
|
|
Term
Describe potassium channels |
|
Definition
1-selectively permeable to potassium, 2-many types of potassium channels, 3-set resting membrane potential, 4-contribute to the plateau, 5-repolarize the cell to terminate the action potential |
|
|
Term
Are there slow or fast opening voltage-gated calcium channels in phase 0 depolarization? |
|
Definition
|
|
Term
What phase is the NO plateau phase? |
|
Definition
|
|
Term
What occurs during phase 3? |
|
Definition
Potassium channel repolarization |
|
|
Term
Phase 4 results from activation of what current? |
|
Definition
The "FUNNY" current, haha! (Slowly depolarizing inward current activated by hyperpolarization) |
|
|
Term
What does the "FUNNY" channel cause? |
|
Definition
Causes slow gradual depolarization during phase 4 in pacemaker (SA nodal) cells |
|
|
Term
What are methods for calcium influx? |
|
Definition
1-triggers calcium release from internal stores (Junctional sarcoplasmic reticulum), 2-stimulates the opening of intracellular calcium channels (ryanodine receptors), 3-calcium induced calcium release |
|
|
Term
|
Definition
1-pumped back into the SR by Calcium ATPase, 2-Shunted out of the cell by a Na/Ca exchanger |
|
|
Term
If cardiac potential generation and propogation becomed unordered, unpredictable, and uncoordinated, what occurs? |
|
Definition
|
|
Term
Proper depolarization resulst in an increase in what? |
|
Definition
|
|
Term
Increased calcium leads to what? |
|
Definition
|
|
Term
Arrhythmias result from disorders of what? |
|
Definition
Impulse formation, coduction or both |
|
|
Term
What are the four potential pacemaker sites in the heart? |
|
Definition
SA node atrial foci, AV node, ventricular foci |
|
|
Term
When do new pacemaker sites become dominant |
|
Definition
Slowing of SA firing, abnormal acceleration of an ecotopic site |
|
|
Term
Bradycardia occurs from what type of block? |
|
Definition
|
|
Term
Tachycardia occurs from what kind of circuit? |
|
Definition
|
|
Term
|
Definition
See no QRST wave on EKG, Signal is not making it from the atria to the ventricle. Stopped at AV node |
|
|
Term
Describe Atrial Fibrillation |
|
Definition
Too much depolarization going through the AV node to the ventricles |
|
|
Term
What kind of pathway results from a reentrant arrhythmia |
|
Definition
accessory pathway (Electrical flow does not eliminate itself |
|
|
Term
Main goal of antiarrhythmic drugs? |
|
Definition
Restore cardiac electrial activity, minimize cardiac pump dysfunction, prevent serious arrhythmias from becoming more serious |
|
|
Term
What does the class 1 antiarrhythmic drugs block? |
|
Definition
|
|
Term
There are three groups of class 1 drugs how do they differ |
|
Definition
In how much they slow conduction in sodium channel inhibition ad how they change the refractory period |
|
|
Term
Describe how much each group (1A, 1B, 1C) class 1 drug slows down the Na channel |
|
Definition
Class 1A- Moderate, Class 1B- little, Class 1C-profound |
|
|
Term
Example of Class 1A Na channel blocker |
|
Definition
|
|
Term
Example of Class 1B Na channel blocker |
|
Definition
|
|
Term
Example of Class 1C Na channel blocker |
|
Definition
|
|
Term
Descibe the how class (1A, 1B, 1C) change the refractory period of Na channel |
|
Definition
1A- prolongs, 1B- shortens, 1C- little change |
|
|
Term
Which class 1 blocks the sodium channel |
|
Definition
|
|
Term
What class 1 inactivates the sodium channel |
|
Definition
|
|
Term
Describe Lidocaine effects |
|
Definition
Class 1B Na blocker-
keeps Na channels in the inactivate state
effect is increased in depolarized tissue, decreased automaticity in depolarized cells |
|
|
Term
What are class 2 antiarrhythmic drugs are used for |
|
Definition
|
|
Term
name a B1 selective competitive antagonists |
|
Definition
|
|
Term
What are class 3 antiarrhythmic drugs used for? |
|
Definition
Prolong AP (Action Potential) by blocking K channels |
|
|
Term
Do class 3 antiarrhythmics affect Na channels? |
|
Definition
No- therefore conduction velocity is not decreased |
|
|
Term
Name a class 3 antiarrhythmic |
|
Definition
|
|
Term
What are the side effects for amidoarone |
|
Definition
Because of AP prolongation can cause arrhythmias----THAT’S STUPID |
|
|
Term
What are class 4 antiarrthymics block? |
|
Definition
|
|
Term
Example of calcium channel blockers? |
|
Definition
|
|
Term
What are calcium chanel blockers primary effect on the heart (what node) |
|
Definition
|
|
Term
When do we use calcium channel blockers? |
|
Definition
Decrease ventricular response to atrial fibrillation (Stop vent fib not atrial fibrillation) |
|
|
Term
Which calcium blocker (diltiazem or verapamil decrease cardiac contractility? |
|
Definition
Verapamil- can be a problem in heart failure |
|
|
Term
What antiarrhythmic does digoxin act like? |
|
Definition
|
|
Term
|
Definition
Decrease AV nodal conduction |
|
|
Term
|
Definition
Antiarrhythic and blocks AV nodal conduction |
|
|
Term
3 Ways to increase cardiac performance |
|
Definition
1. Increase B1 adrenergic (sympathetic) Stimulation
2. Increase cardiac myocyte intracellular calcium
3. Enhance the contractile process directly |
|
|
Term
Adrenergic (sympathetic) stimulation |
|
Definition
B1 rector stimulation- increased cardiac myocyte calcium. Happens automatically when cardiac output (and BP) drops during heart failure through the baroreceptor |
|
|
Term
What are some B1 adrenergic stimulation drugs |
|
Definition
Epinephrine, Norepinephrine, Dopamine, Dobutamine |
|
|
Term
Which two drugs are not that useful |
|
Definition
Epinephrine and Norepinephrine bc too much vasoconstriction via the Alpha 1 receptor stimulation in the vasculature |
|
|
Term
|
Definition
Stimulate cardiac B1 receptors to increase cardiac output (heart rate and contractility) (more of a B1 effect than an A1 affect) Short term use |
|
|
Term
|
Definition
Stimulate cardiac B1 receptors to increase cardiac output (heart rate and contractility) (more of a B1 effect than an A1 affect) Short term use |
|
|
Term
Do Dopamine and Dobutamine have a ceiling effect? |
|
Definition
Yes. Both are often a last ditch effort to keep patient alive (not really true in CCU medicine if you know what your doing) |
|
|
Term
Can you use dopamine or dobutamine with a patient taking a B blocker |
|
Definition
|
|
Term
What mechanism do we use to increase cardiac myocyte intracellular Ca |
|
Definition
Calcium induced calcium release- causes contraction |
|
|
Term
2 ways to increase intracellular calcium |
|
Definition
increase calcium influx, decrease calcium efflux |
|
|
Term
What Does PDE type 3 degrade |
|
Definition
|
|
Term
What does PDE type 3 work |
|
Definition
increased PKA activity- increased calcium channel activity- increased ca - increased contraction |
|
|
Term
What is a PDE type 3 inhibitor |
|
Definition
|
|
Term
Does a PDE type 3 inhibitory mimic the effect of a B1 stimulation |
|
Definition
Yes. Mimicks dopamine or dobutamine |
|
|
Term
2nd way to increase intracellular calcium |
|
Definition
|
|
Term
How do we decrease calcium efflux |
|
Definition
inhibition of the Na/Ca exchanger (indirectly by digoxin) |
|
|
Term
|
Definition
Inhibit the Na/K ATPase- Increases intracellular sodium - Na/Ca exchanger is regulated SOLEY by the concentration of sodium and Ca. Increase sodium in the cell will decrease calcium efflux through the exchanger Digoxin can lead to a AV block |
|
|
Term
What are problems associated with increased adrenergic (sympathetic) stimulation and and Increase in cardiac myocyte calcium influx? |
|
Definition
Increase cardiac oxygen demand and an increase in the chance of arrhythmias |
|
|
Term
What process avoids the increase in cardiac oxygen demand and increase in the chance of arrhythmias? |
|
Definition
Enhancing the contractile process directly |
|
|
Term
What drug enhances the contractile process directly |
|
Definition
pimobendan
(pimo is the shit!) |
|
|
Term
|
Definition
increase cardiac contraction by sensitizing the contractile machinery to calcium (related to an increased affinity of troponin C) this effect requires only a small increase in energy (oxygen) consumption
PIMO IS THE SHIT! |
|
|
Term
Is pimobendan associated with arrhythmias? |
|
Definition
|
|
Term
What is Excitation-contraction coupling? |
|
Definition
translation of smooth muscle cell electrical stimulation into contraction |
|
|
Term
|
Definition
Disrupt excitation-contractoin coupling in vascular smooth muscle |
|
|
Term
Do Vasodilators decrease cardiac oxygen demand |
|
Definition
Yes, due to the decreased afterload and or decreased preload |
|
|
Term
What do vasodilators do to the workload of the heart? |
|
Definition
|
|
Term
What affect does the renin-angiotensin-aldosterone system have on Blood V? |
|
Definition
It increases it through aldosterone/adh |
|
|
Term
Angiotensin 2 has what affects |
|
Definition
increased blood volume and vasoCONSTRICTION |
|
|
Term
|
Definition
Conpetitive antagonist of Angiotensin Converting Enzyme (ACE inhibitor) prevents conversion of Ang 1 to Ang 2 |
|
|
Term
|
Definition
A competitive Angiotensin receptor Type 1. |
|
|
Term
Effects of Ang 2 inhibition |
|
Definition
decrease in sympathetic NS activity, decrease vasoconstriction, decrease tubular sodium and water retention, decrease collecting duct water absorption |
|
|
Term
What adernergic receptor do we block to get dialation |
|
Definition
|
|
Term
|
Definition
competitive antagoinsit at A1 receptor AKA alpha blockers |
|
|
Term
Will an Alpha adrenergic antagoinist cause a possible increase in CO? |
|
Definition
Yes, due to vasodialation in the vasculature. USUALLY TEMPORARY |
|
|
Term
What is a calcium channel antagonist? |
|
Definition
inhibits arterial smooth muscle calcium channels- decreases vasoconstriction (promotes vasodilation) |
|
|
Term
What is a calcium channel antagonistic drug? |
|
Definition
|
|
Term
|
Definition
decrease calcium channel activity, DECREASE TOTAL PERIPHERAL RESISTANCE |
|
|
Term
What does Nothin but a G thang have to do with |
|
Definition
NO goes to GC goes to cGMP goes to PKG which promotes smooth muscle relaxation |
|
|
Term
Nitroglycerine- Exogenous NO donors |
|
Definition
Venous dialation at low levels arterial dilation only at high doses, Decreases preload, tolerance develops over time |
|
|
Term
|
Definition
Arterial and venous dilation- decreases preload and decreases afterload. Light sensitive producing cyanide. Freshly prepared soln is slightly brown. |
|
|
Term
|
Definition
a phosphodiesterase type 5 inhibitor- inhibition results in increased levels of cGMP- which end result is vasodialation
(BONER PILLS!! increase blood flow) |
|
|
Term
PDE5 inhibitors (Sildenafil) |
|
Definition
increased cGMP causes smooth muscle relaxation resultion in vasodilation. PDE5 inhibitors prevent the breakdown of cGMP, thereby prolonging its actions
Used to treat pulmonary hypertension in Vet Med. |
|
|
Term
What does hyperpolarization do to the opening of the calcium channel? |
|
Definition
Decreases it thus decreases calcium entry and contraction |
|
|
Term
How would we hyperpolarize smooth mm |
|
Definition
Increase potassium conductance (open potassium channels) |
|
|
Term
|
Definition
Potassium channel activators |
|
|
Term
|
Definition
An agent which produces diuresis |
|
|
Term
|
Definition
Increased urine flow rate |
|
|
Term
Describe how urine is formed? Three steps |
|
Definition
1)Filtered at the glomerulus
2)Selective secretion
3)selective tubular reabsorption |
|
|
Term
What are the major osmolytes being reabsorbed? |
|
Definition
NaCL, Bicarbonate, Calcium |
|
|
Term
Which is greater filtration rate or urine flow rate? |
|
Definition
|
|
Term
Urine volume is determined by? |
|
Definition
Rate of tubular reabsorption of solutes and water |
|
|
Term
What are the major osmolytes being secreted? |
|
Definition
|
|
Term
Major NaCL and H20 reabsorption occurs where? |
|
Definition
|
|
Term
What are some reasons you would use a diuretic? |
|
Definition
Need to reduce extracellular fluid volume (pulmonary congestion, ascites), oliguric renal failure, hypertension (EIPH) in racehorses, promote urinary excretion of selected agents like hypercalcemia |
|
|
Term
Name the 5 classes of diuretics |
|
Definition
Osmotic diuretics
carbonic anhydrase inhibitors
loop diuretics
thiazide diuretics
K+ sparing diuretics |
|
|
Term
What is the main mechanism for osmotic diuretics? |
|
Definition
Amount filtered exceeds tubular transport
(Draw water into urine by osmosis) |
|
|
Term
|
Definition
|
|
Term
What is Mannitol used to treat |
|
Definition
Oliguric renal failure, cerebral edema, acute glaucoma |
|
|
Term
What condition does too much glucose in filtrate lead to? |
|
Definition
Diabetes mellitus- Water trys to dilute all the glucose in the urine leading to a dilute urine and dehydration
another way to think about it: glucose pulls H2O into the urine |
|
|
Term
What is the mechanism of carbonic anhydrase (CA) inhibitors? |
|
Definition
Increase loss of bicarb and increase of urine pH |
|
|
Term
Name a carbonic anhydrase (CA) inhibitors |
|
Definition
|
|
Term
What is carbonic anhydrase inhibitors used to tx? |
|
Definition
Metabolic alkalosis and glaucoma |
|
|
Term
What are some negativve effects of CA |
|
Definition
Alkalinizing effect on urine may cause systemic acidosis, may cause HYPOKALEMIA (due to increase H+/K+ exchange |
|
|
Term
What is the main mechanism for loop diuretics? |
|
Definition
Inhibit NaCL reabsorption in the thick ascending limb of the loop of Henle (Most effective and most comonly used) |
|
|
Term
|
Definition
Furosemide (Lasix, Salix) |
|
|
Term
What are some negative effects of Furosemide (Loop diuretic) |
|
Definition
May cause HYPOKALEMIA, may increase urinary loss of Ca |
|
|
Term
What are Loop diuretics used to tx |
|
Definition
Oliguric renal failure, acute pulmonary hypertension |
|
|
Term
Explain EIPH (Bleeders) in horses? |
|
Definition
Give racehorses furosemide to decrease body fluid, Bronchodilator, and increase urine to mask the presence of other drugs. Known as Bleeders because is can cause nosebleeds in severe cases |
|
|
Term
What is the mechanism for Thiazides |
|
Definition
Blocks Na and Cl symport which makes it so that H20 doesn't follow Na back into the cell thus making a dilute urine. Also increases Ca reabsorption into the interstital space |
|
|
Term
Name a Thiazide and is it used in vet med often |
|
Definition
Chlorothiazide and no commonly for human hypertension |
|
|
Term
When Cholorothiazide is used in vet med what does it tx? |
|
Definition
Nephrogenic diabetes insidpidus, udder edema in cattle, Ca containing uroliths (because of the Ca reabsorption effects) |
|
|
Term
What are the two classes of K+ (Potassium) Sparing Diuretics? |
|
Definition
Competitive Aldosterone Antagonists
Principal cell Na Channel Blockers |
|
|
Term
What K+ Sparing diuretic blocks Aldosterone? |
|
Definition
|
|
Term
Is spironolactone most often used alone or in combo? |
|
Definition
In combo because it causes mild diuresis with reduced K loss |
|
|
Term
What are two K+ Sparing Diuretics that block Prinicpal cell Na channels |
|
Definition
Amiloride and triamterene |
|
|
Term
Do we use Amiloride alone or in combo |
|
Definition
In combo because it’s a mild diuretic effect |
|
|
Term
Lecture 12
Introduction to Autonomic Pharmacology |
|
Definition
|
|
Term
T or F: Organs are innervated by either the sypmathetic NS or the parasympathetic NS |
|
Definition
False: Organs are innervated by BOTH the Sympathetic and Parasympathetic |
|
|
Term
What organ is an exception to the dual ANS innervation? |
|
Definition
|
|
Term
Parasympathetic target organs have _______________ cholinergic receptors |
|
Definition
|
|
Term
Preganglionic neurons (symp and parasymp) release what? |
|
Definition
|
|
Term
Parasympathetic post ganglionic neurons release what? |
|
Definition
|
|
Term
Sympathetic post ganglionic neurons release what? |
|
Definition
|
|
Term
Sympathetic target organs have _______________ cholinergic receptors |
|
Definition
|
|
Term
Adrenergic rece3ptors have what two families |
|
Definition
|
|
Term
What cells release epinephrine? |
|
Definition
|
|
Term
What are four ways to terminate a signal |
|
Definition
re-uptake (presynaptic)
diffusion
degradation
uptake (post synaptic) |
|
|
Term
|
Definition
epinephrine
norepinephrine
dopamine |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
Can a catecholamine be degraded? |
|
Definition
|
|
Term
What is the primary route of inactivation of Catecholamines? |
|
Definition
|
|
Term
What does cholinergic mean? |
|
Definition
nerves that are stimulated by Ach |
|
|
Term
How does a nicotinic receptor work? |
|
Definition
Ach binds to the receptor which opens the receptor and allows for the sodium influx |
|
|
Term
What are the types of muscarinic cholinergic receptors? |
|
Definition
|
|
Term
What are the types of adrenergic alpha receptors? |
|
Definition
|
|
Term
What are the types of Adrenergic beta receptors? |
|
Definition
Beta 1 and Beta 2(and beta 3) |
|
|
Term
Muscarinic cholinergic, adrenergic alpha and adrenergic beta are all what kind of receptors |
|
Definition
|
|
Term
Which adrenergic receptor increases heart rate, conduction, and contraction of the heart? |
|
Definition
|
|
Term
Which cholinergic receptor decreases heart rate, conduction and contraction in heart? |
|
Definition
|
|
Term
What do sypmathetic innervation do to blood vessels |
|
Definition
directs blood flow to skeletal m. Constriction |
|
|
Term
Lecture 13
Cholinergic Pharmacology |
|
Definition
|
|
Term
Cholinergic Agonists. AKA- parasympathomimetics |
|
Definition
Mimic/ enhance the effects of endogenously released ACh. |
|
|
Term
Major Effects of Cholinergic Agonists |
|
Definition
Heart (M2): decreased CO via bradycardia by decreased SA nodal automaticity, decreased conduction via AV node, decreased contractility.
Vasculature (M3): vasodilation via increased NO.
Lungs (M3 and M2): bronchoconstriction, increased secretions.
GI (M3 predomiately, M2): increased motility, increased secretions (salivation).
Urinary (M3): promotes micturition.
Eye (M3 and M2): lacrimation, miosis, loss of accommodation to far vision. |
|
|
Term
Cholinergic Agonists- Excess Signs |
|
Definition
SLUDGE- Salivation, Lacrimation, Urination, Defecation, GI Signs, Emesis;
DUMBELS- Diarrhea and diaphoresis, Urination, Miosis, Bronchorrhea/ Brochospasm/ bradycardia, Emesis, Lacrimation, Salivation. |
|
|
Term
Direct Acting Cholinergic Agonist |
|
Definition
R- mACh
Ex-endogenous Ach |
|
|
Term
Indirect Acting Cholinergic Agonist |
|
Definition
R- mACh
Ex-AChE (Acetylcholinesterase) inhibitors (prevent the breakdown of Ach) |
|
|
Term
|
Definition
Direct Acting Cholinergic Agonist.
R- mACh and nACh.
Rarely used clincially except in Ophthamic.
Rapid degradation by AChE and in plasma= VERY SHORT HALF LIFE |
|
|
Term
|
Definition
naturally occuring chemical compounds containing basic nitrogen atoms |
|
|
Term
Direct Acting Cholinergic Agonists
Cholinomimetic Alkoloids |
|
Definition
|
|
Term
Direct Acting Cholinergic Agonists
Synthetic Choline esters |
|
Definition
Bethanechol, methacholine, carbachol |
|
|
Term
|
Definition
Direct Acting Cholinergic Agonist.
R- some M3 selectivity (GI and Uriniary Bladder).
Promotes voiding by contraction of the destusor and relexation of the trigone and sphincter,
**contraindicated in uretheral obstruction** |
|
|
Term
|
Definition
Direct Acting Cholinergic Agonist.
R- muscarinic (allowed for the discovery of the mACh receptor.
Found in mushrooms. |
|
|
Term
|
Definition
Multiple toxins present- Muscarine.
Signs- DUMBELS and SLUDGE |
|
|
Term
|
Definition
Direct Acting Cholinergic Agonist.
R- mACh.
Use- topical ophthalmic (to induse miosis, and decrease IOP) rarely used to systemically promote salivation. |
|
|
Term
Acetylcholinesterase Inhibitors |
|
Definition
Indirect Acting Cholinergic Agonist.
Prevent hydrolysis of Ach. Leads to accululation of Ach at site of release (autonomic effector organs and ganglia, skeletal mm, cholinergic synapses in CNS. |
|
|
Term
Pharamacological Effects of AChE Inhibitors |
|
Definition
Stimulation of autonomic effector organs via mACh.
Simulation then depression of autonomic ganglia and skeletal mm via nACh.
Stimulation then depression of cholinergic receptors in the CNS. |
|
|
Term
Categories of AChE Inhibitors |
|
Definition
Non-Covalent- completely reversibble interaction, competitive antagonists.
Reversiable Covalent.
Irreversiable Covalent |
|
|
Term
Edrophonium (not that important) |
|
Definition
Non-Covalent inhibitor (competitive antagonists) quaternary compound (No CNS effects)
Used to Dx myasthenia gravis (Ach receptor deficiency).
Rapid renal elimination (short duration of action) |
|
|
Term
Reversiable covalent AChE Inhibitors |
|
Definition
Physostigmine and Neostigmine.
Uses- smooth mm atony (GI and Urinary), Glaucoma (topical decrease IOP), reversal of competitive non-depolarizing NMJ blocking agents, Tx- myasthenia gravis, counter CNS symptoms of anticholinergic intoxication (physostigmine).
*Physostigmine not quaternary and crosses blood brain barrier.* |
|
|
Term
Irreversiable Covalent AChE Inhibitors |
|
Definition
Organophosphates
Insecticides (ie- malathion)
nerve gases (ie- sarin). |
|
|
Term
|
Definition
Signs- SLUDGE, colic, shock, hypotension.
Tx- possible if early w/ cholinesterase reactivators (pralidoxime, 2-PAM); symptomatically w/ anticholinergics (will affect both mACh and nACh) |
|
|
Term
Cholinergic Antagonists
AKA- parasympatholytics or Anticholinergics |
|
Definition
Block the effects of endogenous ACh @ mACh (little effect at nACh)
General classification: direct acting competive antagonists (reversiably block the stimulation of mACh by Ach) |
|
|
Term
Groups of Anticholinergics |
|
Definition
Natural anticholinergic alkaloids (ie- atropine, scopolamine)
Semi-synthetic and synthetic alkaloids (ie- tropicamide, ipratropium, glycopyrrolate, propantheline.) |
|
|
Term
Effects of Anticholinergics |
|
Definition
Heart: increased CO (via tachycardia- increased SA nodal automaticity and increased conduction via the AV node.)
Vasculature: little to no effect (no innervation by parasypathetic NS).
Lungs: bronchodilation, decreased secretions.
GI: decreased motility, decreased secretion (dry mouth).
Urinary: decreased contraction (decreased micturition).
Eye: decreased lacrimation, mydriasis, cyclopegia (paralysis of the ciliary m. resulting in loss of accommodation.) |
|
|
Term
Signs of Anticholinergic Drugs |
|
Definition
Anti-SLUDGE/ Anti-DUMBELS
**NOTE- some sites are more sensitive than others, anticholinergic effects also depends on the degree of parasympathetic tone
(remember its balance b/w sympathetic and parasympathetic tone) |
|
|
Term
|
Definition
Anticholinergic.
Competitively inhibits the binding and stimulation of mACh by ACh. Enters the CNS (non-quaternary) possible toxicity (excitation then depression).
Concerns- tachyarrhythmia, GI stasis (esp. in horses), urine retention.
Use- during general anestheisa (decrease respirtory secretions, increase HR), tx of AChE inhibitor poisoning. [increased salivation possible if topical sol. for eye drains into mouth b/c its very bitter (stimulates salivation)] |
|
|
Term
|
Definition
Cholinergic antagonist
similar effects as atropine
Enters the CNS: low dose: slight sedation; high dose: excitement; antiemetic (not generally the drug of choice). |
|
|
Term
|
Definition
Cholinergic antagonist
Similar to atropine but quaternary= little CNS effects.
Uses: Anesthesia- decrease salivary and airway secretions, prevent vagally-mediated bradycardia
|
|
|
Term
|
Definition
Cholinergic antagonist
Uses: ophthalmic exam topically to produce
mydriasis and cycloplegia (loss of ability
to maintain focus on an object as it draws
near the eye)
shorter duration of action |
|
|
Term
|
Definition
Cholinergic antagonist
decreased bronchoconstriction and airway secretions
Use: asthma (cats), chronic bronchitis (dogs), horses with recurrent airway inflammation |
|
|
Term
|
Definition
Cholinergic antagonist
decreases detrusor contraction, incresases trigone and sphincter contraction
***promotes urine retention***
Uses: treat incontinence due to detrusor instability |
|
|
Term
LECTURE 14
Neuromuscular Junction Blockers |
|
Definition
|
|
Term
General Uses of NMJ Blockers |
|
Definition
adjunct during general
anesthesia to: relax skeletal muscle (no sedative effects). NO ANALGESIA!!!! :(
Causes profound relaxation
Can be used to facilitate: tracheal intubation, orthopedic manipulations, balanced anesthesia, any time that skeletal muscle paralysis is
desired.
|
|
|
Term
Is the nACh receptor at the NMJ different from other nACh receptors and why would we care? |
|
Definition
YES it is some what different.
We care b/c this differnce allows for differential pharmacology
Allows for selectivity (gangilonic vs NMJ blockers) |
|
|
Term
T/F
For muscle contraction not all nicotinic receptors need to be activiated by ACh. |
|
Definition
TRUE
B/c of spare receptors
Provides a saftey factor at the NMJ (think about the diaphragm)
In general with NMJ blockers: need to block more receptors than expected, absence of clinical blockade with drug present (sub-threshold), reversal of clinical blockade with drug still present |
|
|
Term
Competitive NMJ blockers
AKA non-depolarizing NMJ blockers |
|
Definition
No motor end plate depolarization
Initial muscle weakness followed by
flaccid paralysis
Examples: pancuronium (long acting), Atracurium (intermediate), Mivacurium (short acting)
|
|
|
Term
|
Definition
Competitive NMJ blocker
long duration of action (2-3 hours) (renal elim- so even longer if renal dz)
Other: little ganglionic blockade, no histamine release, blocks muscarinic receptors (tachycardia)
|
|
|
Term
|
Definition
Competitive NMJ blocker
intermediate duration (0.5 -1 h)
spontaneous degradation (temp and pH dependent) + hydrolysis by
plasma esterases + renal elimination (1/2 life not effected by renal dz)
little/no ganglionic blockade and promotes histamine release |
|
|
Term
|
Definition
Competitive NMJ blocker
short duration of action (15 min)
rapid hydrolysis by plasma esterases (1/2 life not effected by renal dz)
little/no ganglionic blockade and promotes histamine release |
|
|
Term
T/F
Action of competive NMJ blockers is pharmacologically reversible
with acetylcholinesterase inhibitors |
|
Definition
TRUE
physostigmine and neostigmine act by increasing ACh via esterase inhibition allows
for ACh to out-compete the competitive
antagonists |
|
|
Term
Depolarizing NMJ blockers
AKA non-competitive NMJ blockers |
|
Definition
Cause prolonged motor end plate
depolarization by stimulation of NMJ
nicotinic receptors
Initial muscle fasciculations (uncoordinated
contractions) followed by relaxation |
|
|
Term
|
Definition
Depolarizing NMJ blocker
resistant to acetylcholinesterase and not pharmacologically reversible
rapid onset (1 min) and Ultra short acting (5 mins)
useful for rapid and short lived NMJ
blockade (e.g. facilitate tracheal
intubation)
Other considerations: some histamine release and can cause hyperkalemia from release of intracellular
potassium from skeletal muscles |
|
|
Term
Phases of Depolarizing NMJ blockers |
|
Definition
Early (phase I): depolarization
– fasciculations to flaccid paralysis
Late (phase II): repolarization
– flaccid paralysis
– resembles receptor desensitization |
|
|
Term
Potential problem with NMJ block |
|
Definition
Monitoring depth of anesthesia
Many signs of anesthesic depth (palpebral, toe pinch, corneal, jaw tone) are lost during
neuromuscular blockade
Must look at other parameters: BP, HR, temp, and ECG to asses depth.
The principal source of distress in
anesthetized patients is often respiratory so even closer observation of sPO2, ETCO2, and RR. |
|
|
Term
General NMJ blockade toxicity
Respiratory paralysis |
|
Definition
Ganglionic blockade- diaphragm stops contracting
histamine release (leading to vasodilation, hypotention, bronchospasm, ↑ resp. secretions and saliva)
consider pre-tx w/ diphenhydramine |
|
|
Term
NMJB toxicity interventions
Vagal (parasympathetic) reflex |
|
Definition
often procedure (not drug) induced (e.g. visceral manipulation)
Can cause and/ or compound signs of histamine release (bradycardia, bronchospasm, hypotension,
bronchial and salivary secretion) |
|
|
Term
General NMJ blockade toxicity
Malignant hyperthermia |
|
Definition
life-threatening; excessive contracture and heat production from skeletal muscle; initiated by the release of calcium from the sarcoplasmic reticulum of skeletal muscle
usually a combination of halogenated
anesthetics (e.g. halothane) and
succinylcholine
prevalent in pigs, also reported in dogs
(especially Greyhounds), cats, and horses.
Tx- dantrolene (drug that limits SR
calcium release) plus supportive measures (rapid cooling, oxygen…) |
|
|
Term
Lec 15 & 16
Adrenergic Pharmacology
|
|
Definition
|
|
Term
Adrenergic agonists
AKA-Sympathomimetics |
|
Definition
Mimic the effect of endogenous
sympathetic catecholamine (EPI and NorEPI)
neurotransmitters
|
|
|
Term
General classification of agonists |
|
Definition
Direct acting agonists
– endogenous catecholamines
Indirect acting agonists
– amphetamine
Mixed acting agonists
– Phenylpropanolamine (PPA) |
|
|
Term
|
Definition
Direct acting adrenergic agonist (alpha and Beta)
Effects: ↑ HR, automaticity, conduction velocity, contraction (B1) Result: ↑ CO. Ateries constrict (A1) Skeletal ateries dilate (B2). Bronchodilator (B2)
Low dose: ↓ BP via B2 dominance (vasodilation in skel. mm)
High dose: ↑ BP via A1 (also ↑ CO)
Uses: cardiac arrest, anaphylaxis |
|
|
Term
|
Definition
direct A and B receptor agonist
A1: EPI = NE
– B2: EPI >>>>> NE
– B1: EPI > NE
Effects: sames as EPI except no B2 stim. (no bronchodilation) and more intense vasoconstriction = ↑ BP which causes vagal reflex= slow HR.
Uses: maintain BP |
|
|
Term
|
Definition
Endogenous catecholamine
Short half life (must be given via CRI)
low dose (1-10 μg/kg): stimulates vascular D1 dopamine receptors, ↑ renal blood flow and sodium
excretion, + inotropic effect (↑ CO)
Higher dose (>10 μg/kg): stimulate vascular A1 receptors, vasoconstriction, ↓ renal blood flow.
Uses: Renal Failure, low dose for CHF with compromised renal function |
|
|
Term
|
Definition
Non-selective B adrenergic agonist
Mostly B1 little B2
↑ cardiac contractility (B1 agonist)
with minimal changes in HR
Use: as + inotrope during CHF |
|
|
Term
Selective B2 adrenergic agonists |
|
Definition
B2 agonist = bronchodilator
Minimal Cardio effects esp. when aeroslized
prolonged duration of action
Drugs: Albuterol (Bronchospasm in K-9, fel, EQ)
Clenbuterol (used for allergic bronchitis, recurrent airway
obstruction (“heaves”), and bronchoconstriction
in EQ)
Prolonged use can cause B receptor down regulation w/ chronic admin and over-useage. Minimize with proper dosing and dosing schedule. |
|
|
Term
Selective A1 adrenergic agonists
Phenylephrine |
|
Definition
A1 agonist = vasoconstrictor
Primary effect of A1 stimulation is
constriction of vascular smooth muscle
causes: ↑ TPR, ↑ BP (pressor agent), nasal decongestant.
Phenylephrine: topical, oral and parenteral decongenstant/ vasopressor |
|
|
Term
Selective A2 adrenergic agonists
(dex)medetomidine (and xylazine) |
|
Definition
Effect primarily central (CNS) and presynaptic
inhibition of sympathetic neurons
Causes: sedation, analgesia, ↓ sympathetic outflow from brain
(dex)medetomidine (and xylazine): widely used as adjunct for sedation, anesthesia, and analgesia in veterinary medicine; allows for a lower dose of other
anesthetic/analgesic agents with lower
safety profiles |
|
|
Term
Adrenergic antagonists
AKA Sympatholytics |
|
Definition
Block the effect of endogenous sympathetic catecholamines
effects dependent on sympathetic activity (tone)
Classes:
-Direct acting competitive antagonists (reversiable)
-Direct acting non-competitive antagonists (irreversiable) |
|
|
Term
|
Definition
Direct acting non-competitive antagonist
irreversibly blocks A1 and A2 receptors
Causes: reduced urethral sphincter tone
Used to manage urethral blockage |
|
|
Term
|
Definition
Direct acting competitive antagonist
reversibly blocks A1 and A2 receptors
reduces urethral sphincter tone
manage urethral blockage |
|
|
Term
|
Definition
Selective A1 adrenergic antagonists
major effect is to relax arterial and venous
smooth muscle = vasodilation; ↓ TPR and venous return (preload)
Uses: antihypertensive and in CHF (reduced pre-and after-load) produce less reflex tachycardia than other
vasodilation agents |
|
|
Term
Atipamezole
(also yohimbine) |
|
Definition
selective A2 antagonists (competitive)
used to reverse sedative and analgesic
effects of medetomidine
also increases sympathetic activity |
|
|
Term
|
Definition
block endogenous NE and EPI
resulting in decreased heart rate and
cardiac contractility
magnitude dependent on sympathetic tone
(consider exercise and stress) |
|
|
Term
B1 adrenergic antagonists |
|
Definition
Decreased HR and cardiac contractility.
↓ cardiac output, ↓ cardiac oxygen demand, ↓ BP
excessive sympathetic stimulation is proarrythmogenic,
↓ cardiac arrhythmias |
|
|
Term
B2 adrenergic antagonists |
|
Definition
↑ bronchoconstriction (BAD! BADNESS!!)
is not generally a desirable effect, major limitation
of non-selective B antagonists |
|
|
Term
|
Definition
Nonselective B adrenergic antagonist -↓ cardiac output (B1 blockade)
-antiarrhythmic action from ↓ sympathetic stimulation and non-adrenergic effects (e.g. “membrane stabilization”) limited use b/c of B2 blockade and
availability relatively selective B1 inhibitors |
|
|
Term
|
Definition
Nonselective B adrenergic antagonists
ocular use to decrease aqueous
humor production during glaucoma |
|
|
Term
|
Definition
Selective B1 adrenergic antagonists
Selectivity is relative, block B2 receptors at higher doses.
↓ HR and cardiac contractility, counteract anticholinergic tachycardia, ↓ cardiac output, ↓ cardiac oxygen demand and ↓ cardiac arrhythmias
potentially useful in feline hypertrophic cardiomyopathy |
|
|
Term
|
Definition
• Used in veterinary medicine
– Congestive heart failure
– Valvular disease
• Unique non-selective B antagonist
– Blocks B1 (good) and B2 receptors (bad)
– Blocks B1 (vasculature) receptors
– Antioxidant properties |
|
|